Lipid Metabolism — MCQs
On this page
A 45-year-old male presents for a routine checkup. He has a history of hypertension and diabetes, for which he is on medication. General examination reveals a random blood sugar of 180 mg/dl and elevated HDL levels. Which of the following statements regarding the lipoprotein levels of this patient is not true?
Fatty acids help in the synthesis of all except:
What is the consequence of a lack of beta-oxidation of fatty acids?
Which membrane phospholipid does not contain glycerol?
Dietary cholesterol is transported to extrahepatic tissues by which of the following?
Which of the following fatty acids present in fish oil is known for its cardio-protective function?
Niemann-Pick disease is characterized by?
Which of the following is not a lipotropic factor?
Malonyl CoA:ACP transacylase has the activity of how many enzymes?
Lack of alpha-oxidation of fatty acids leads to which of the following?
Lipid Metabolism Indian Medical PG Practice Questions and MCQs
Question 11: A 45-year-old male presents for a routine checkup. He has a history of hypertension and diabetes, for which he is on medication. General examination reveals a random blood sugar of 180 mg/dl and elevated HDL levels. Which of the following statements regarding the lipoprotein levels of this patient is not true?
- A. Directly related to the incidence of atherosclerosis (Correct Answer)
- B. Varies reciprocally with plasma triacylglycerol concentrations
- C. Varies directly with the activity of lipoprotein lipase
- D. It is rich in cholesterol, and its sole apolipoprotein is apo E
Explanation: **Explanation:** The question asks for the **incorrect** statement regarding HDL (High-Density Lipoprotein). **1. Why Option A is the Correct Answer (The False Statement):** HDL is known as "good cholesterol" because it mediates **reverse cholesterol transport**, carrying excess cholesterol from peripheral tissues back to the liver for excretion. Therefore, HDL levels are **inversely related** to the incidence of atherosclerosis and coronary artery disease (CAD). A high HDL level is cardioprotective, not a risk factor for atherosclerosis. **2. Analysis of Incorrect Options (True Statements):** * **Option B:** HDL levels typically vary **reciprocally** with plasma triacylglycerol (TAG) concentrations. High TAG levels often lead to increased exchange of TAG for cholesterol esters in HDL via CETP, making HDL particles smaller and more prone to clearance, thus lowering HDL levels. * **Option C:** Lipoprotein Lipase (LPL) hydrolyzes TAGs in VLDL and chylomicrons. The surface remnants (phospholipids and apoproteins) generated during this process are transferred to HDL. Thus, increased LPL activity **directly** correlates with higher HDL levels. * **Option D:** While mature HDL contains various apoproteins (A-I, C, E), a specific subtype known as **HDL-with-E** (or HDLc) is rich in cholesterol and contains **apo E** as its sole apolipoprotein, allowing it to bind to LDL receptors. **Clinical Pearls for NEET-PG:** * **Apo A-I:** The primary apoprotein and activator of LCAT in HDL. * **LCAT (Lecithin-Cholesterol Acyltransferase):** Converts free cholesterol into cholesterol esters within HDL, transforming discoid nascent HDL into spherical mature HDL. * **CETP (Cholesteryl Ester Transfer Protein):** Exchanges HDL-cholesterol esters for VLDL-triacylglycerols. * **Tangier Disease:** A rare genetic disorder caused by ABCA1 transporter deficiency, leading to near-zero HDL levels and orange tonsils.
Question 12: Fatty acids help in the synthesis of all except:
- A. Glucose (Correct Answer)
- B. Cholesterol
- C. Ketone bodies
- D. Fat
Explanation: ### Explanation **1. Why Glucose is the Correct Answer (The Underlying Concept)** In humans, fatty acids **cannot** be converted into glucose. This is because the reaction catalyzed by the **Pyruvate Dehydrogenase (PDH) complex** (Pyruvate → Acetyl CoA) is **irreversible**. Fatty acid oxidation yields Acetyl CoA. While Acetyl CoA enters the TCA cycle, the two carbons it contributes are lost as $CO_2$ before reaching Oxaloacetate (the precursor for gluconeogenesis). Therefore, there is no net gain of carbon atoms to support glucose synthesis. *Note:* The only exception is odd-chain fatty acids, which yield Propionyl CoA; this can be converted to Succinyl CoA and eventually glucose. However, standard fatty acids are even-chained. **2. Why the Other Options are Incorrect** * **B. Cholesterol:** Acetyl CoA produced from fatty acid $\beta$-oxidation is the primary building block for cholesterol synthesis via the HMG-CoA reductase pathway. * **C. Ketone Bodies:** During starvation or uncontrolled diabetes, excess Acetyl CoA from fatty acids is diverted to the liver's ketogenic pathway to form acetoacetate and $\beta$-hydroxybutyrate. * **D. Fat (Triacylglycerols):** Fatty acids are the primary structural component of fats. They esterify with glycerol-3-phosphate to form triglycerides for storage in adipose tissue. **3. High-Yield Clinical Pearls for NEET-PG** * **The "No-Go" Rule:** Acetyl CoA can never be converted back to Pyruvate in animals. * **Odd-Chain Exception:** Propionyl CoA is the **only** part of an even/odd fatty acid breakdown that is **glucogenic**. * **Key Enzyme:** Pyruvate Carboxylase (Pyruvate → Oxaloacetate) is the bridge that allows non-carbohydrate sources to enter gluconeogenesis, but it requires ATP and Biotin. * **Energy Source:** While fatty acids don't provide carbons for glucose, their oxidation provides the **ATP and NADH** required to drive the energy-expensive process of gluconeogenesis.
Question 13: What is the consequence of a lack of beta-oxidation of fatty acids?
- A. Oxidation of branched chain fatty acids
- B. Phytanic acid accumulation
- C. Dicarboxylic acid accumulation (Correct Answer)
- D. Formation of propionic acid
Explanation: **Explanation:** When **$\beta$-oxidation** (the primary pathway for fatty acid breakdown in mitochondria) is impaired—due to enzyme deficiencies like MCAD deficiency or systemic conditions—the body activates an alternative pathway known as **$\omega$-oxidation** (omega-oxidation). 1. **Why Option C is correct:** $\omega$-oxidation occurs in the **endoplasmic reticulum** and involves the oxidation of the terminal methyl group (the omega carbon) of fatty acids. This process converts the fatty acid into a **dicarboxylic acid**. Under normal conditions, this is a minor pathway; however, when $\beta$-oxidation fails, dicarboxylic acids accumulate in the blood and are excreted in the urine (**dicarboxylic aciduria**). This is a classic biochemical marker for fatty acid oxidation disorders. 2. **Why other options are incorrect:** * **Option A & B:** These refer to **$\alpha$-oxidation**, which is the pathway used for **branched-chain fatty acids** (like phytanic acid). A defect here leads to Refsum disease, not a lack of $\beta$-oxidation. * **Option D:** Propionic acid is produced during the oxidation of **odd-chain fatty acids**. It is a normal intermediate and not a consequence of failed $\beta$-oxidation. **High-Yield Clinical Pearls for NEET-PG:** * **MCAD Deficiency:** The most common defect of $\beta$-oxidation. It presents with **non-ketotic hypoglycemia** and dicarboxylic aciduria during fasting. * **$\omega$-oxidation enzymes:** Requires Cytochrome P450, NADPH, and $O_2$. * **Zellweger Syndrome:** Failure to oxidize very-long-chain fatty acids (VLCFAs) due to peroxisomal biogenesis defects.
Question 14: Which membrane phospholipid does not contain glycerol?
- A. Lecithin
- B. Cardiolipin
- C. Sphingomyelin (Correct Answer)
- D. Cellulose
Explanation: **Explanation:** The core concept tested here is the structural classification of phospholipids. Phospholipids are divided into two categories based on their backbone: **Glycerophospholipids** (glycerol backbone) and **Sphingophospholipids** (sphingosine backbone). **Why Sphingomyelin is correct:** Sphingomyelin is the only significant membrane phospholipid that is **not** derived from glycerol. Instead, it contains **sphingosine**, an 18-carbon amino alcohol. Its structure consists of a sphingosine backbone attached to a fatty acid (forming Ceramide) and a phosphorylcholine head group. It is a major component of the myelin sheath in nervous tissue. **Analysis of Incorrect Options:** * **Lecithin (Phosphatidylcholine):** This is the most abundant glycerophospholipid in cell membranes. It consists of a glycerol backbone, two fatty acids, and a phosphate group attached to choline. * **Cardiolipin (Diphosphatidylglycerol):** Found exclusively in the inner mitochondrial membrane, it consists of two molecules of phosphatidic acid linked by a glycerol bridge. It contains three glycerol units in total. * **Cellulose:** This is a structural polysaccharide (carbohydrate) made of glucose units linked by $\beta(1\to4)$ glycosidic bonds. It is not a phospholipid or even a lipid. **NEET-PG High-Yield Pearls:** * **Niemann-Pick Disease:** A lysosomal storage disorder caused by a deficiency in **Sphingomyelinase**, leading to the accumulation of sphingomyelin (look for "cherry-red spot" on the macula and hepatosplenomegaly). * **L/S Ratio:** The Lecithin/Sphingomyelin ratio in amniotic fluid is used to assess fetal lung maturity. A ratio $>2$ indicates mature lungs. * **Cardiolipin Clinical Link:** It is the antigen used in the **VDRL test** for Syphilis and is targeted by antibodies in Antiphospholipid Antibody Syndrome (APS).
Question 15: Dietary cholesterol is transported to extrahepatic tissues by which of the following?
- A. Very-low-density lipoprotein (VLDL)
- B. Low-density lipoprotein (LDL) (Correct Answer)
- C. Chylomicrons
- D. High-density lipoprotein (HDL)
Explanation: **Explanation:** The transport of cholesterol in the body follows a specific pathway based on its origin (exogenous vs. endogenous). **1. Why LDL is correct:** Low-density lipoprotein (LDL) is the primary carrier of cholesterol to extrahepatic tissues. It is formed from the metabolism of VLDL via IDL. LDL contains a high concentration of cholesterol esters and expresses **Apo B-100**, which acts as a ligand for LDL receptors on peripheral tissues. Once bound, the cholesterol is internalized via receptor-mediated endocytosis, providing the necessary lipids for cell membrane synthesis and steroidogenesis. **2. Why other options are incorrect:** * **VLDL (Very-low-density lipoprotein):** Produced by the liver, its primary role is the transport of **endogenous triglycerides** to peripheral tissues, not dietary cholesterol. * **Chylomicrons:** These transport **dietary (exogenous) lipids** from the intestines. However, they primarily deliver triglycerides to muscle and adipose tissue. The remaining "Chylomicron remnants" (containing the dietary cholesterol) are taken up by the **liver**, not extrahepatic tissues. * **HDL (High-density lipoprotein):** Known for **"Reverse Cholesterol Transport,"** HDL picks up excess cholesterol from peripheral tissues and transports it back to the liver for excretion in bile. **Clinical Pearls for NEET-PG:** * **LDL** is often termed "Bad Cholesterol" because high levels lead to atherosclerosis. * **Rate-limiting enzyme** of cholesterol synthesis: HMG-CoA Reductase (inhibited by Statins). * **Apo B-48** is the marker for Chylomicrons (exogenous pathway); **Apo B-100** is the marker for VLDL/LDL (endogenous pathway). * **Type IIa Hyperlipoproteinemia** is characterized by a deficiency in LDL receptors, leading to significantly elevated serum LDL.
Question 16: Which of the following fatty acids present in fish oil is known for its cardio-protective function?
- A. Arachidonic acid
- B. Eicosapentaenoic acid (Correct Answer)
- C. Linoleic acid
- D. Palmitic acid
Explanation: **Explanation:** The correct answer is **Eicosapentaenoic acid (EPA)**. EPA, along with Docosahexaenoic acid (DHA), belongs to the **Omega-3 (ω-3)** family of polyunsaturated fatty acids (PUFAs). These are abundant in fish oils and are highly cardio-protective because they reduce plasma triglycerides, inhibit platelet aggregation (by shifting the balance toward PGI3), and possess potent anti-inflammatory properties. **Analysis of Options:** * **Arachidonic acid (Option A):** An Omega-6 fatty acid that serves as a precursor for pro-inflammatory eicosanoids (like PGE2 and LTB4). While essential, an excess is often associated with pro-thrombotic states. * **Linoleic acid (Option B):** An essential Omega-6 fatty acid found primarily in vegetable oils. While it lowers LDL cholesterol, it is not the specific "fish oil" component famed for direct cardio-protection in the same capacity as EPA. * **Palmitic acid (Option D):** A 16-carbon saturated fatty acid. High intake of saturated fats is generally associated with increased LDL levels and higher cardiovascular risk. **High-Yield NEET-PG Pearls:** * **Omega-3 vs. Omega-6:** Omega-3 (EPA/DHA) is anti-inflammatory; Omega-6 (Arachidonic acid) is generally pro-inflammatory. * **Essential Fatty Acids:** Linoleic acid (ω-6) and Linolenic acid (ω-3) are essential because humans lack enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) to introduce double bonds beyond carbon 9. * **Mechanism:** EPA competes with arachidonic acid for the enzyme cyclooxygenase, leading to the production of Thromboxane A3 (a weak aggregator) instead of Thromboxane A2 (a strong aggregator), thereby preventing clots.
Question 17: Niemann-Pick disease is characterized by?
- A. Increased concentration of sphingomyelin in liver (Correct Answer)
- B. Increased concentration of cerebrosides in liver and spleen.
- C. Increased concentration of plasminogen
- D. Increased accumulation of glycerol in liver
Explanation: **Explanation:** **Niemann-Pick Disease (Type A and B)** is a lysosomal storage disorder caused by a deficiency of the enzyme **Acid Sphingomyelinase (ASM)**. 1. **Why Option A is Correct:** Under normal conditions, ASM breaks down sphingomyelin into ceramide and phosphorylcholine. In its absence, **sphingomyelin** cannot be degraded and accumulates within the lysosomes of the reticuloendothelial system, particularly in the **liver, spleen, and bone marrow**. This leads to massive hepatosplenomegaly and the presence of characteristic "Foam cells" (lipid-laden macrophages). 2. **Why Incorrect Options are Wrong:** * **Option B:** Accumulation of **glucocerebrosides** in the liver and spleen is the hallmark of **Gaucher’s disease** (the most common lysosomal storage disorder), caused by a deficiency of β-glucosidase. * **Option C:** Plasminogen is a precursor to plasmin involved in fibrinolysis; it has no metabolic link to Niemann-Pick disease. * **Option D:** Glycerol accumulation is not a feature of sphingolipidoses; these diseases involve complex lipids, not simple triacylglycerol components. **High-Yield Clinical Pearls for NEET-PG:** * **Cherry-red spot:** Present on the macula in Type A (similar to Tay-Sachs). * **Foam Cells:** Histology shows "mulberry-like" or "soap-bubble" appearance of macrophages. * **Genetics:** Autosomal Recessive inheritance. * **Type A vs. B:** Type A is the severe infantile form with neurodegeneration; Type B is the non-neuropathic form presenting with organomegaly. * **Mnemonic:** "No-man picks (Niemann-Pick) his nose with a **Foamy** finger to eat a **Cherry**."
Question 18: Which of the following is not a lipotropic factor?
- A. Choline
- B. Lecithin
- C. Arginine (Correct Answer)
- D. Methionine
Explanation: **Explanation:** Lipotropic factors are substances required for the normal mobilization of fat from the liver. A deficiency of these factors leads to the excessive accumulation of triacylglycerols in the hepatocytes, resulting in a **fatty liver**. **Why Arginine is the correct answer:** Arginine is a basic amino acid primarily involved in the urea cycle and protein synthesis. It does not play a direct role in the synthesis of phospholipids or the export of Very Low-Density Lipoproteins (VLDL) from the liver. Therefore, it is **not** a lipotropic factor. **Analysis of other options:** * **Choline:** It is the most significant lipotropic factor. It is a precursor for phosphatidylcholine (Lecithin), which is an essential component of the VLDL shell required for transporting fat out of the liver. * **Lecithin (Phosphatidylcholine):** As a key structural component of lipoproteins, it ensures that hydrophobic lipids remain miscible in the plasma for export. * **Methionine:** This is an essential sulfur-containing amino acid that acts as a methyl donor (via S-adenosylmethionine). It provides the methyl groups necessary for the *de novo* synthesis of choline from phosphatidylethanolamine. **High-Yield NEET-PG Pearls:** 1. **Mechanism:** Lipotropic factors prevent fatty liver by promoting the synthesis of **VLDLs**, which are the primary vehicles for exporting endogenous triglycerides from the liver. 2. **Other Lipotropic Factors:** Inositol, Betaine, Vitamin B12, and Folic acid (the latter two assist in methionine metabolism). 3. **Clinical Correlation:** Chronic alcoholism and protein-energy malnutrition (Kwashiorkor) often lead to fatty liver due to a deficiency in these lipotropic agents and apolipoproteins.
Question 19: Malonyl CoA:ACP transacylase has the activity of how many enzymes?
- A. 1
- B. 2 (Correct Answer)
- C. 3
- D. 4
Explanation: In Fatty Acid Synthesis, the **Fatty Acid Synthase (FAS) multienzyme complex** in humans is a dimer of two identical polypeptide chains. Each monomer contains seven catalytic domains. ### **Why Option B is Correct** The enzyme **Malonyl CoA:ACP transacylase (MAT)** is unique because it is a **bifunctional enzyme**. In the human FAS complex, a single catalytic domain possesses **two distinct enzymatic activities**: 1. **Acetyl transacylase activity:** It transfers the acetyl group from Acetyl-CoA to the Acyl Carrier Protein (ACP) to prime the synthesis. 2. **Malonyl transacylase activity:** It transfers the malonyl group from Malonyl-CoA to the ACP for chain elongation. While in prokaryotes (Type II FAS) these are separate enzymes, in eukaryotes (Type I FAS), they are combined into one functional unit, making "2" the correct number of activities. ### **Why Other Options are Incorrect** * **Option A:** Incorrect because the domain handles both Acetyl and Malonyl substrates, not just one. * **Options C & D:** Incorrect because the other five activities of the FAS complex (Ketoacyl synthase, Reductase, Dehydratase, etc.) are attributed to distinct domains within the polypeptide chain. ### **High-Yield Clinical Pearls for NEET-PG** * **Rate-Limiting Step:** The conversion of Acetyl-CoA to Malonyl-CoA by **Acetyl-CoA Carboxylase (ACC)** (requires Biotin). * **Inhibitor:** Malonyl-CoA inhibits **Carnitine Palmitoyltransferase-I (CPT-I)**, preventing a "futile cycle" by stopping fatty acid oxidation while synthesis is active. * **End Product:** The FAS complex exclusively produces **Palmitate (C16)**. Further elongation occurs in the endoplasmic reticulum. * **Reductant:** **NADPH** is the essential electron donor, primarily sourced from the Hexose Monophosphate (HMP) Shunt.
Question 20: Lack of alpha-oxidation of fatty acids leads to which of the following?
- A. Accumulation of phytanic acid (Correct Answer)
- B. Formation of dicarboxylic acid
- C. Formation of propionic acid
- D. Oxidation of branched chain fatty acid
Explanation: **Explanation:** **Alpha-oxidation** is a specialized pathway occurring in the **peroxisomes** that is essential for the breakdown of **branched-chain fatty acids**, such as **phytanic acid**. Phytanic acid is derived from chlorophyll in the diet (dairy and meat). Because it has a methyl group at the beta-carbon, it cannot undergo standard beta-oxidation. Alpha-oxidation removes one carbon atom at a time from the carboxyl end, "shifting" the methyl group to the alpha-position, thereby allowing subsequent beta-oxidation to proceed. * **Option A (Correct):** A deficiency in the enzyme **Phytanoyl-CoA hydroxylase** (the first step of alpha-oxidation) leads to the toxic accumulation of phytanic acid in tissues and serum, a condition known as **Refsum disease**. * **Option B (Incorrect):** Formation of dicarboxylic acids occurs via **omega-oxidation** (in the ER), which becomes prominent when beta-oxidation is impaired (e.g., MCAD deficiency). * **Option C (Incorrect):** Propionic acid is a normal end-product of the beta-oxidation of **odd-chain fatty acids**, not a result of failed alpha-oxidation. * **Option D (Incorrect):** This is the process that *fails* to occur; lack of alpha-oxidation prevents the oxidation of branched-chain fatty acids. **Clinical Pearls for NEET-PG:** 1. **Refsum Disease:** Characterized by the clinical triad of **Retinitis pigmentosa, Peripheral neuropathy, and Cerebellar ataxia**. Treatment involves a diet free of chlorophyll/phytanic acid. 2. **Zellweger Syndrome:** A generalized defect in peroxisome biogenesis affecting multiple pathways, including alpha and beta-oxidation of very-long-chain fatty acids (VLCFA). 3. **Location:** Remember that alpha-oxidation occurs exclusively in **peroxisomes**, not mitochondria.
Practice by Chapter
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free